Abstract
Purpose
The Chronic Liver Disease Questionnaire (CLDQ)-Nonalcoholic Fatty Liver Disease (NAFLD) is a disease-specific instrument to assess the health-related quality of life (HRQL) of patients with NAFLD. In order to provide further evidence for the cross-cultural utility of this instrument in the Chinese population, we translated the CLDQ-NAFLD into Chinese and examined its reliability and validity.
Methods
Patients with NAFLD in 90 hospitals across China were enrolled in this multicenter cross-sectional survey. Eligible patients completed the Chinese version of CLDQ-NAFLD at enrollment to assess HRQL. Internal consistency of the questionnaire was assessed using Cronbach’s alpha coefficient and split-half reliability. Convergent and discriminant validity were assessed using Spearman correlation coefficient. Factor analysis was used to test the construct validity.
Results
Between March and August 2019, 5181 patients with a mean age of 43.8 ± 13.3 years were enrolled. All domains exhibited good internal consistency, with Cronbach’s alpha and split-half reliability greater than 0.70. The scaling success rate of all domains was 100% for convergent validity and 99.4% (179/180) for discriminant validity. The inter-scale correlations indicated a significant correlation between all CLDQ-NAFLD domains (r = 0.608 to 0.832, all p < 0.001). Factor analysis of 36 items extracted 6 factors, which explained 69.14% of the total variance.
Conclusion
The Chinese version of CLDQ-NAFLD is a reliable and valid instrument for assessing the HRQL of Chinese patients with NAFLD.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Code availability
Not Applicable.
Abbreviations
- NAFLD:
-
Non-alcoholic fatty liver disease
- HRQL:
-
Health-related quality of life
- CLDQ:
-
Chronic liver disease questionnaire
- SD:
-
Standard deviations
References
Tanaka, N., Kimura, T., Fujimori, N., Nagaya, T., Komatsu, M., & Tanaka, E. (2019). Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology, 25(2), 163–177.
Younossi, Z. M., Stepanova, M., Henry, L., Racila, A., Lam, B., Pham, H. T., & Hunt, S. (2017). A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD. Liver International, 37(8), 1209–1218.
Zhou, F., Zhou, J., Wang, W., Zhang, X. J., Ji, Y. X., Zhang, P., She, Z. G., Zhu, L., Cai, J., & Li, H. (2019). Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis. Hepatology, 70(4), 1119–1133.
Yuksel, H., Yilmaz, O., Dogru, D., Karadag, B., Unal, F., & Quittner, A. L. (2013). Reliability and validity of the cystic fibrosis questionnaire-revised for children and parents in Turkey: Cross-sectional study. Quality of Life Research, 22(2), 409–414.
Tourani, S., Behzadifar, M., Martini, M., Aryankhesal, A., Taheri Mirghaed, M., Salemi, M., Behzadifar, M., & Bragazzi, N. L. (2018). Health-related quality of life among healthy elderly Iranians: A systematic review and meta-analysis of the literature. Health and Quality of Life Outcomes, 16(1), 18.
Martinez-Martin, P., Rodriguez-Blazquez, C., Kurtis, M. M., & Chaudhuri, K. R. (2011). The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Movement Disorders, 26(3), 399–406.
Mahmoudi, H., Jafari, P., Alizadeh-Naini, M., Gholami, S., Malek-Hosseini, S. A., & Ghaffaripour, S. (2012). Validity and reliability of persian version of chronic liver disease questionnaire (CLDQ). Quality of Life Research, 21(8), 1479–1485.
Zhou, K. N., Zhang, M., Wu, Q., Ji, Z. H., Zhang, X. M., & Zhuang, G. H. (2013). Reliability, validity and sensitivity of the Chinese (simple) short form 36 health survey version 2 (SF-36v2) in patients with chronic hepatitis B. Journal of Viral Hepatitis, 20(4), e47-55.
Chang, P. E., Tan, H. K., Lee, Y., Fook-Chong, S., Chia, P. Y., Shaik-Hussain, N., Lee, H. L., & Aloweni, F. (2020). Clinical validation of the chronic liver disease questionnaire for the Chinese population in Singapore. JGH Open, 4(2), 191–197.
Morooka, Y., Umeshita, K., Taketomi, A., Shirabe, K., Maehara, Y., Yamamoto, M., Shimamura, T., Oshita, A., Kanno, K., Ohdan, H., Kawagishi, N., Satomi, S., Ogawa, K., Hagiwara, K., & Nagano, H. (2013). Reliability and validity of a new living liver donor quality of life scale. Surgery Today, 43(7), 732–740.
Yamamura, S., Nakano, D., Hashida, R., Tsutsumi, T., Kawaguchi, T., Okada, M., Isoda, H., Takahashi, H., Matsuse, H., Eguchi, Y., Sumida, Y., Nakajima, A., Gerber, L., Younossi, Z. M., & Torimura, T. (2021). Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of chronic liver disease questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology, 36(3), 629–636.
Funuyet-Salas, J., Pérez-San-Gregorio, M., Martín-Rodríguez, A., & Romero-Gómez, M. (2021). Quality of life and coping in nonalcoholic fatty liver disease: influence of diabetes and obesity. International Journal of Environmental Research and Public Health, 18(7), 3503.
Bellavance, D., & Halegoua-Demarzio, D. (2021). Health related quality of life varies by weight loss method in patients with history of nonalcoholic fatty liver disease. Advances in Digestive Medicine, 8(2), 105–111.
Acquadro, C., Conway, K., Hareendran, A., & Aaronson, N. (2008). Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Health, 11(3), 509–521.
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., & Erikson, P. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (pro) measures: Report of the ISPOR task force for translation and cultural adaptation. Value Health, 8(2), 94–104.
Huber, Y., Boyle, M., Hallsworth, K., Tiniakos, D., Straub, B. K., Labenz, C., Ruckes, C., Galle, P. R., Romero-Gómez, M., Anstee, Q. M., & Schattenberg, J. M. (2019). Health-related quality of life in nonalcoholic fatty liver disease associates with hepatic inflammation. Clinical Gastroenterology and Hepatology, 17(10), 2085-2092.e2081.
Sayiner, M., Stepanova, M., Pham, H., Noor, B., Walters, M., & Younossi, Z. M. (2016). Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease. BMJ Open Gastroenterology, 3(1), e000106.
Golabi, P., Otgonsuren, M., Cable, R., Felix, S., Koenig, A., Sayiner, M., & Younossi, Z. M. (2016). Non-alcoholic fatty liver disease (nafld) is associated with impairment of health related quality of life (HRQOL). Health and Quality of Life Outcomes, 14, 18.
Czakon, W., Klimas, P., & Mariani, M. (2020). Behavioral antecedents of coopetition: A synthesis and measurement scale. Long Range Planning, 53(1), 101875.
Lam, E. T., Lam, C. L., Lai, C. L., Yuen, M. F., & Fong, D. Y. (2009). Psychometrics of the chronic liver disease questionnaire for Southern Chinese patients with chronic hepatitis B virus infection. World Journal of Gastroenterology, 15(26), 3288–3297.
Acknowledgements
Language editing services provided by Meg.Tang of MIMS Shanghai Limited., funded by Sanofi (China) Investment Co., Ltd.
Funding
This work was supported by National Natural Science Foundation of China [Grant No. 81870406], and National Natural Science Foundation of China [Grant no. 81870407].
Author information
Authors and Affiliations
Contributions
R.H., H.R. and L.W: conception and design. All authors: data collection. R.H., H.R. and L.W: data analysis and interpretation. All authors: providing materials and samples. R.H: drafting article. All the authors have read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
H Rao has received speaking fees from Bristol-Myers Squibb, Gilead, and AbbVie. L Wei has received research support and/or consulting fees from Abbvie, Bristol-Myers Squibb, Gilead, Roche, and Novartis. R Huang, J Fan, J Shi, Y Mao, B Wang, J Zhao, L Lu, B Zhong, Z Zou, Y Xu, Y Ye, L Liu and L Lin certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
Ethical approval
This study was approved by the Institutional Review Board of Peking University People’s Hospital (2018PHB259-01). Written informed consent was obtained from each patient.
Consent for publication
Not applicable.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, R., Fan, JG., Shi, JP. et al. Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China. Qual Life Res 32, 915–922 (2023). https://doi.org/10.1007/s11136-022-03305-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-022-03305-w